Boehringer Ingelheim Venture Fund
Mark Ralph is a member of Boehringer Ingelheim’s Venture Fund focused on digital health investments with particular interest in digital therapeutics, digital augmentation of traditional therapeutics, and the use of digital technology for patient adherence, disease diagnosis and monitoring. Prior to joining the Fund, Mark was the Global Head of Contracts and Alliance Management, a team within Business Development and licensing that was responsible for leading contract negotiations and the alliance management of collaborations with academic and biotechnology partners. Mark has over 18 years of experience in the pharmaceutical industry and has taken on diverse roles spanning drug discovery, operations, CRO management, financial management, and business development.
Mark is attending / has attended:
Sign up now to stay up-to-date with all our events, news, deals and more!